It was a mistake to hire Catherine Mazzacco as CEO of Leo Pharma, says a headhunter focused on the pharmaceutical industry, who predicts that the board will look internationally to find her replacement.
by albert rønning-andersson, translated by catherine brett
After two years as CEO of Leo Pharma, Catherine Mazzacco is stepping down with immediate effect.
In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.
The US retail chain has stopped selling its own private label hearing aids – and until the next generation comes along, other hearing companies selling products via Costco are enjoying the empty shelf space.